HHS will move Merck’s Covid antiviral Lagevrio to commercial distributionnews2023-10-05T18:58:04+00:00October 5th, 2023|Endpoints News|
Bausch Health’s Salix tackles stigma around brain condition caused by acute liver diseasenews2023-10-05T18:50:45+00:00October 5th, 2023|Endpoints News|
Lilly says about 70% of patients taking tirzepatide experienced an adverse eventnews2023-10-05T18:11:01+00:00October 5th, 2023|Endpoints News|
Reagan-Udall Foundation lays out methods for FDA to combat misinformationnews2023-10-05T18:10:06+00:00October 5th, 2023|Endpoints News|
Braeburn’s opioid use disorder drug Brixadi enters the market with flexible dosingnews2023-10-05T18:05:34+00:00October 5th, 2023|Endpoints News|
Lonza boosts ADC supply capacity through partnership expansion with unnamed major pharmanews2023-10-05T16:16:35+00:00October 5th, 2023|Endpoints News|
Viatris downsizes; Biovectra partners with Acuitas; Pfizer’s Hospira recalls injections; WuXi secures two new dealsnews2023-10-05T16:04:41+00:00October 5th, 2023|Endpoints News|
Health tech startups Commure and Athelas are merging with a $70M boost from General Catalystnews2023-10-05T15:16:44+00:00October 5th, 2023|Endpoints News|
Neurocrine reports a second PhIII success in congenital adrenal hyperplasia, this time in childrennews2023-10-05T15:14:11+00:00October 5th, 2023|Endpoints News|
Longeveron touts PhIIa Alzheimer’s data, but drug’s future remains murkynews2023-10-05T15:00:06+00:00October 5th, 2023|Endpoints News|
